Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116758093 | 11675809 | 3 | F | 20150923 | 20160916 | 20151028 | 20160922 | EXP | US-REGENERON PHARMACEUTICALS, INC.-2015-13167 | REGENERON | 0.00 | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116758093 | 11675809 | 1 | PS | EYLEA | AFLIBERCEPT | 1 | Intraocular | 2 MG MILLIGRAM(S), MONTHLY | N | U | 125387 | 2 | MG | INJECTION | |||||
| 116758093 | 11675809 | 2 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | LEFT EYE | N | U | 125387 | INJECTION | |||||||
| 116758093 | 11675809 | 3 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | LEFT EYE | N | U | 125387 | INJECTION | |||||||
| 116758093 | 11675809 | 4 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | LEFT EYE | N | U | 125387 | INJECTION | |||||||
| 116758093 | 11675809 | 5 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | LEFT EYE | N | U | 125387 | INJECTION | |||||||
| 116758093 | 11675809 | 6 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | RIGHT EYE | N | U | 125387 | INJECTION | |||||||
| 116758093 | 11675809 | 7 | SS | COUMADIN | WARFARIN SODIUM | 1 | N | U | 0 | ||||||||||
| 116758093 | 11675809 | 8 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116758093 | 11675809 | 1 | Neovascular age-related macular degeneration |
| 116758093 | 11675809 | 2 | Macular oedema |
| 116758093 | 11675809 | 3 | Retinal vein occlusion |
| 116758093 | 11675809 | 7 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116758093 | 11675809 | DS |
| 116758093 | 11675809 | HO |
| 116758093 | 11675809 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116758093 | 11675809 | Blindness | |
| 116758093 | 11675809 | Cerebral haemorrhage | |
| 116758093 | 11675809 | Haemorrhagic stroke | |
| 116758093 | 11675809 | Hemianopia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116758093 | 11675809 | 1 | 20150320 | 20151104 | 0 | |
| 116758093 | 11675809 | 2 | 201504 | 201504 | 0 | |
| 116758093 | 11675809 | 3 | 201505 | 201505 | 0 | |
| 116758093 | 11675809 | 4 | 201507 | 201507 | 0 | |
| 116758093 | 11675809 | 5 | 201509 | 201509 | 0 | |
| 116758093 | 11675809 | 6 | 20150911 | 20150911 | 0 |